Novogenia AG (FRA:7V0)

Germany flag Germany · Delayed Price · Currency is EUR
5.70
-0.60 (-9.52%)
At close: Jul 17, 2026
Market Cap78.00M -11.0%
Revenue (ttm)54.30M -59.2%
Net Income545.47K -97.7%
EPS0.05 -97.7%
Shares Out n/a
PE Ratio143.00
Forward PEn/a
Dividend0.56 (7.94%)
Ex-Dividend DateJun 29, 2026
Volumen/a
Open5.70
Previous Close6.30
Day's Range5.70 - 5.70
52-Week Range5.50 - 12.10
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateSep 8, 2026

About Novogenia AG

Novogenia AG operates in the healthcare industry. The company offers dietary supplements and cosmetics products. It also provides consulting and support services. The company was formerly known as Darwin AG and changed its name to Novogenia AG in June 2026. The company was incorporated in 2021 and is based in Munich, Germany. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2021
Employees 204
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 7V0

Financial Performance

In 2025, Novogenia AG's revenue was 54.30 million, an increase of 98.53% compared to the previous year's 27.35 million. Earnings were 545,469, a decrease of -97.04%.

Financial Statements